HBK Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-15,021
Closed -$483K 1282
2018
Q4
$483K Sell
15,021
-15,979
-52% -$603K 0.01% 899
2018
Q3
$1.33M Buy
31,000
+3,800
+14% +$180K 0.01% 645
2018
Q2
$1.25M Buy
27,200
+9,700
+55% +$429K 0.01% 589
2018
Q1
$695K Sell
17,500
-2,500
-13% -$92.6K ﹤0.01% 697
2017
Q4
$670K Sell
20,000
-4,610
-19% -$164K 0.01% 686
2017
Q3
$912K Sell
24,610
-11,890
-33% -$446K 0.01% 651
2017
Q2
$1.35M Buy
36,500
+25,500
+232% +$832K 0.01% 503
2017
Q1
$309K Buy
+11,000
New +$310K ﹤0.01% 580

Other funds holding PAHC

HBK Investments's PAHC Position: Q1 2019 in Review

HBK Investments sold out of Phibro Animal Health (PAHC) in Q1 2019, closing a stake of 15,021 shares — an estimated $483K sold.

HBK Investments first reported a position in PAHC in Q1 2017 and held it in 8 quarters. The position peaked at $1.35M in Q2 2017. 176 funds tracked by Wall St. Rank hold PAHC as of Q1 2019.

  • HBK Investments reported no remaining Phibro Animal Health position as of Q1 2019 after selling out during the quarter.
  • HBK Investments sold 15,021 Phibro Animal Health shares in Q1 2019, an estimated $483K.
  • HBK Investments first reported a position in Phibro Animal Health in Q1 2017 and held it in 8 quarters.
  • HBK Investments's Phibro Animal Health position peaked at $1.35M in Q2 2017.
  • 176 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.